FDA Inspection 1026876 — Siteselect Inc. (D.B.A. Lexcii Medical)
The FDA completed an inspection of Siteselect Inc. (D.B.A. Lexcii Medical) on August 24, 2017 in Vicksburg, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 24, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Vicksburg, MI (United States)